Your browser doesn't support javascript.
loading
Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants.
Sasi, Sharath P; Bae, Sanggyu; Song, Jin; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph; Yan, Xinhua; Kishore, Raj; Enderling, Heiko; Goukassian, David A.
Affiliation
  • Sasi SP; Cardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, United States of America.
  • Bae S; Cardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, United States of America; Departments of Medicine and Pathology, Steward St. Elizabeth' Medical Center, Boston, Massachusetts, United States of America.
  • Song J; Cardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, United States of America.
  • Perepletchikov A; Departments of Medicine and Pathology, Steward St. Elizabeth' Medical Center, Boston, Massachusetts, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Schneider D; Departments of Medicine and Pathology, Steward St. Elizabeth' Medical Center, Boston, Massachusetts, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Carrozza J; Departments of Medicine and Pathology, Steward St. Elizabeth' Medical Center, Boston, Massachusetts, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Yan X; Cardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Kishore R; Feinberg Cardiovascular Institute, Northwestern University, Chicago, Illinois, United States of America.
  • Enderling H; Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
  • Goukassian DA; Cardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, United States of America; Tufts University School of Medicine, Boston, Massachusetts, United States of America.
PLoS One ; 9(3): e92373, 2014.
Article in En | MEDLINE | ID: mdl-24664144
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Tumor Necrosis Factor-alpha / Carcinoma, Lewis Lung / Receptors, Tumor Necrosis Factor, Type II / Gene Knockdown Techniques Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Tumor Necrosis Factor-alpha / Carcinoma, Lewis Lung / Receptors, Tumor Necrosis Factor, Type II / Gene Knockdown Techniques Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Country of publication: